35th EACTS
CytoSorbents Symposium 1
14. Oktober, 2021 | 12:45-14:00 CET | Raum 113
Hemoadsorption with CytoSorb in various cardiac surgery indications
Vorsitz: Christian Hagl, München, Deutschland
- Removal of Ticagrelor to reduce bleeding complications and costs in high urgency operations
Stephan Geidel, Hamburg, Deutschland - The challenge to master refractory vasoplegic shock
Nandor Marczin, Harefield, UK - Feasibility and safety aspects in heart transplantation
Endre Németh, Budapest, Ungarn - ECMO in combination with hemoadsorption in cardiac surgery patients
Leonardo Gottin, Verona, Italien
CytoSorbents Symposium 2
15. Oktober, 2021 | 12:45-14:00 CET | Raum 113
Role of CytoSorb hemoadsorption therapy in endocarditis patients
Vorsitz: Carlos Mestres, Zürich, Schweiz
- Intraoperative use – First results from the REMOVE trial
Torsten Doenst, Jena, Deutschland - Intraoperative and postoperative use – Which patients benefit most?
Daniel Wendt, Essen, Deutschland - Can hemoadsorption reduce the amount of postoperative vasoactive drugs?
Anna Holmén, Gothenburg, Schweden - We need an individualized approach – Results of a large retrospective study
Jurij Kalisnik, Nürnberg, Deutschland
Angemeldete Teilnehmer können das Symposium auch im Livestream auf der EACTS-Website verfolgen!